TOCILIZUMAB

UNII:	I031V2H011
Formula:
Preferred Substance Name:	TOCILIZUMAB

375823-41-9
ACTEMRA
ATLIZUMAB
AVTOZMA
BAT1806
BAT-1806
BIIB800
BIIB-800
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
MRA
MSB11456
MSB-11456
R-1569
RG-1569
RGB19
RGB-19
RHPM-1
RO-4877533
ROACTEMRA
TOCILIZUMAB (GENETICAL RECOMBINATION)
TOCILIZUMAB [EMA EPAR]
TOCILIZUMAB [INN]
TOCILIZUMAB [JAN]
TOCILIZUMAB [MART.]
TOCILIZUMAB [MI]
TOCILIZUMAB [PURPLE BOOK CDER]
TOCILIZUMAB [USAN]
TOCILIZUMAB [VANDF]
TOCILIZUMAB [WHO-DD]
TOCILIZUMAB BIOSIMILAR (BAT-1806)
TOCILIZUMAB BIOSIMILAR (MSB11456)
TOCILIZUMAB BIOSIMILAR (RGB-19)
TOCILIZUMAB-AAZG
TOCILIZUMAB-ANOH
TOCILIZUMAB-BAVI
TOFIDENCE
TYENNE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TOCILIZUMAB

Synonyms and Mappings

Resources